Deepak Nitrite Infuses ₹135 Cr into Subsidiary DCTL

Key Highlights • Total infusion: ₹135 crore – ₹110 Cr by Deepak Phenolics – ₹25 Cr by Deepak Nitrite • Funds infused into Deepak Chem Tech Ltd (DCTL) • Purpose: Strengthen capital base & support expansion projects • Ownership remains 100% with the group Business Focus • DCTL operates in fluorination, nitration, and specialty chemicals Why It Matters Capital infusion supports expansion in high-value specialty chemicals, which typically offer better margins and growth opportunities. Learning Outcome Investments in subsidiaries often indicate focus on future growth areas. Investors should track capex deployment and segment profitability to assess long-term value creation.